Cerity Partners’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Cerity Partners's CSTL Position: Q3 2026 in Review
Cerity Partners opened a new position in Castle Biosciences (CSTL) in Q3 2026: 6,784 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #2961 among its holdings. This is a return to the name: Cerity Partners previously reported a position in CSTL as recently as Q1 2025.
Cerity Partners first reported a position in CSTL in Q1 2025 and has held it in 2 quarters since. The position peaked at $423K in Q1 2025. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Cerity Partners held 6,784 shares of Castle Biosciences worth $241K as of Q3 2026.
- Castle Biosciences was a new Cerity Partners position in Q3 2026.
- Castle Biosciences made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #2961 holding.
- Cerity Partners first reported a position in Castle Biosciences in Q1 2025 and has held it in 2 quarters since.
- Cerity Partners's Castle Biosciences position peaked at $423K in Q1 2025.
- 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.